Company intelligence / Profile preview

Propath UK

Hereford, Herefordshire, United Kingdom

Ownership: Private
Employees: ~155
Development stage: Other

Overview

Propath UK is a leading CRO specializing in molecular pathology and histopathology, offering services in spatial biology for biopharma R&D. It collaborates with pharmaceutical and biotechnology companies to advance clinical and pre-clinical programs.

Therapeutic areas: Oncology
Modalities: Immunofluorescence Multiplexing (High-Plex IHC)Spatial ProteomicsTranscriptomics
Industry: Contract Research Organization

Partnerships

Nucleai: For AI-powered spatial analysis in immuno-oncology.Lunaphore: Utilizing the COMET platform for hyperplex IHC analysis.

Beyond the preview

Go deeper on Propath UK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Propath UK.

Explore the full profile